Related Experiment Video
Updated: Jan 19, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Perspectives on Acute Hepatitis A Control in Korea
Seong Hee Kang1,2, Moon Young Kim1,2, Soon Koo Baik1,3
1Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
A nationwide Hepatitis A outbreak in Korea, peaking in 2009, has led to a rise in cases, particularly among young adults. This highlights the urgent need for effective Hepatitis A control and prevention strategies for vulnerable populations.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Hepatitis A incidence in Korea was minimal until 1995, with a significant nationwide outbreak peaking in 2009.
- In 2019, over 10,000 acute Hepatitis A cases were reported, indicating a resurgence.
- Declining seropositivity for anti-hepatitis A virus antibodies (anti-HAV) in adults aged 20-30 suggests waning herd immunity.
Purpose of the Study:
- To analyze the current epidemiological trends of acute Hepatitis A in Korea.
- To identify vulnerable populations susceptible to Hepatitis A infection.
- To emphasize the need for targeted control and prevention strategies.
Main Methods:
- Analysis of reported acute Hepatitis A cases from the Korea Center for Disease Control and Prevention.
- Review of seropositivity rates for anti-HAV antibodies in different adult age groups over time.
- Epidemiological assessment of population susceptibility.
Main Results:
- A significant increase in acute Hepatitis A cases reported in 2019.
- Lowest anti-HAV antibody seropositivity rates observed in adults in their 20s.
- A continuous decline in anti-HAV seropositivity among adults in their 30s since 2005.
- Young adults (20s and 30s) represent a vulnerable population due to lack of prior infection or vaccination.
Conclusions:
- The current epidemic of Hepatitis A in Korea is a predictable outcome of decreased population immunity.
- Effective control and prevention strategies are crucial, especially for adults in their 20s and 30s.
- Public health interventions should focus on increasing vaccination rates and awareness in susceptible demographics.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Acute Pancreatitis II: Clinical Manifestations and Management
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

